Author - Ziad

Pixability Joins Global Alliance for Responsible Media (GARM) Providing Contextual, Brand Safety and Suitability Expertise to Industry Standardization Efforts

Pixability, the only provider of software and insights for video advertising on YouTube and other leading connected TV (CTV) platforms, today announced it has become an official member of the Global Alliance for Responsible Media (GARM), the cross-industry initiative established by the World Federation of Advertisers (WFA). The company has been tapped to play a leading role in helping to establish contextual, brand safety and suitability guidelines for the advertising industry while increasing trust and transparency for advertisers. Pixability […]

Winning With Talent: Inside Six Boston Tech Companies Hiring Now

Boston is a city of legendary talent. Beantown’s sport legacies, etched along its historic streets, whisper the names of athletes that once called the city home — Brady and Belichick, Bird and Russell, Ruth and Ortiz. Its world-renowned universities have sent recruited emissaries far and wide as intellectual standard-bearers of academic prestige. The fabric of Boston and Cambridge’s historic DNA comprises cutting-edge personnel, weaved together with more than 1,000 biotech companies, from homegrown startups to multinational conglomerates. …To see […]

Vanguard Partners With Candidly For Student Loan Repayment Program

Vanguard has partnered with Candidly to offer retirement plan sponsors a student loan debt repayment program option for eligible employees. The financial wellness service will be available to Vanguard recordkeeping clients as an opt-in feature. Vanguard expects to make the Candidly platform available in the second half of 2022. Workers with student loan debt often have difficulty reaching their financial goals. Financial planning and saving for retirement are complicated, and can be delayed because of student loan debt, says […]

ZetrOZ Shares Insights for Providers and Patients Seeking Insurance Coverage on Novel Medical Technologies for Advanced Treatments

New medical technologies bring better outcomes to patients and more efficiency to the U.S. healthcare industry, but some insurers and care providers slow its adoption, according to ZetrOZ Systems, a leading innovator and inventor of sustained acoustic medicine for soft tissue injury healing. With more than 100,000 patients treated, George K. Lewis, Ph.D. and CEO of ZetrOZ Systems said, ZetrOZ has learned that a key to winning insurance provider approval of novel medical devices and therapies is thorough advance […]

Biolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine

Akston Biosciences Corporation and Biolexis, a Strides Group Company, today announced results from a Phase II/III clinical trial in India of the SARS-CoV-2 vaccine, AKS-452, in which 1,600 healthy volunteers participated – 100 in an open-label bridging study and 1,500 in Phase II/III, double-blind, placebo-controlled trial. An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56. Volunteers in the bridging study had antibody titers that persisted at statistically-significant high levels […]

FutureFuel.io Acquires College Finance Company to Expand Beyond Student Debt, Rebrands to Candidly

FutureFuel.io, the market’s most comprehensive student debt management platform, today announced the acquisition of College Finance Company, the leading multi-lender marketplace for education financing. The company also announced a complete rebrand of its corporate identity, including a new logo, updated visual brand elements, and a new company name: Candidly. Read more >>

Astrocyte Announces Initiation of First-In-Human Phase 1 Study of the Promising Stroke and Traumatic Brain Injury Therapeutic, AST-004

Astrocyte Pharmaceuticals Inc., a drug discovery and development company advancing novel cerebroprotective therapeutics for patients with brain injuries, announced that the Company’s first-in-human Phase 1 clinical study initiated today with the dosing of a first subject with AST-004. The promising investigational therapeutic, AST-004, is being advanced as a potential acute treatment for stroke and traumatic brain injury (TBI) victims, and as a chronic treatment for neurodegenerative diseases like Alzheimer’s. AST-004 has demonstrated a broad range of cerebroprotective efficacy when […]

Wasabi Technologies Doubles Down on APAC Expansion with Singapore Storage Region

Wasabi Technologies, the hot cloud storage company, reaffirmed its commitment to the Asia-Pacific market with the opening of a new storage region located in Singapore. This marks Wasabi’s 13th storage region globally and its fourth in APAC, following Tokyo, Osaka, and most recently Sydney, as the company scales to meet the demand for high-performance, affordable cloud storage, and to be in closer proximity to its expansive customer and partner network. Read more >>

Zylö Therapeutics Closes $5.225 Million Series B Financing

Zylö Therapeutics Inc., dedicated to developing a transformational drug-delivery platform, announced that it has raised $5.225 million in its Series B financing. The Series B round was led by a consortium of seasoned investors, spearheaded by James Cordes, who recently joined the Zylö board of directors. Other key participants were: (i) VentureSouth (which led the Series A round) which invested more than $1.3 million in the Series B round; (ii) the New York Angels, an angel group that has […]